Pharmaceuticals
Healthcare
Sun Pharma gets High Court nod for acquiring Ranbaxy
The High Court of Punjab and Haryana has orally approved the merger of Sun Pharmaceutical Industries and Ranbaxy Laboratories, as ......
Healthcare
US court quashes Ranbaxy's plea against FDA on Nexium, Valcyte generic
A US court has dismissed a plea by Ranbaxy challenging the American drug regulator's move to revoke the 180-day exclusivity ......
Healthcare
Sun Pharma to buy GSK's opiates business in Australia
Sun Pharmaceutical Industries Ltd, the country's most valued pharma company, is buying GlaxoSmithKline's (GSK) opiates business in Australia for an ......
Healthcare
Shasun exiting Ascent Capital-backed veterinary products JV with SeQuent for $12M
Chennai-based Shasun Pharmaceuticals Ltd is selling its stake in veterinary company Alivira Animal Health as post its merger with Strides ......
Healthcare
Motilal Oswal PE invests in Ahmedabad-based Arinna Lifesciences
Motilal Oswal Private Equity Advisors Pvt Ltd (MOPE), the PE arm of Motilal Oswal Financial Services Ltd, has invested close ......
Healthcare
Ipca Labs picks 19% stake in Krebs Biochem, hiking it to 30%; makes open offer
Mumbai-based Ipca Laboratories Ltd, which manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, has picked close to 19 per ......
Healthcare
ChrysCapital raises stake in Ipca Labs for around $20M
Private equity major ChrysCapital has hiked its holding in drug-maker Ipca Laboratories Ltd by shelling out close to $20 million ......
Healthcare
Cipla forms JV with existing partners Cooper Pharma and PHI in Morocco
Mumbai-based drug maker Cipla Limited has entered into a joint venture agreement with two of its existing business partners in ......
Healthcare
AIF Capital-backed Famy Care selling part of business to Mylan for up to $800M
US-based generic drugmaker Mylan Inc has struck a deal to buy a part of female health care businesses from Mumbai-based ......
Healthcare
Sun Pharma gets US FTC nod to buy Ranbaxy
The US Federal Trade Commission (FTC) has approved the proposed $4-billion buyout of Ranbaxy Laboratories by Sun Pharmaceutical, the companies ......